glp-1 blockers in fast food Friendly: How Big is trying to leverage the GLP-1 weight loss drug fad GLP-1s are saving people from

Patients should stop eating when satisfied rather than finishing everything on the platea practice that may require overcoming social or cultural norms about food waste

While the drugs have helped people lose substantial amounts of weight, potential side effects range from nausea, bloating, diarrhoea and fatigue, to more serious stomach, kidney and gallbladder problems and inflammation of the pancreas

A spokesperson for Eli Lilly, the maker of Mounjaro and Zepbound, said the company values efforts to make healthy living easier for everyone. When restaurants offer more menu options and flexible portion sizes they help empower diners, including those managing complex conditions like obesity and diabetes, to make healthier decisions and reduce food waste, the Lilly spokesperson said in a statement

E., Elliott, E

Nutrition Journal , 10(1), 93